December 2011. Volume 7. Number 4

Propranolol therapy for infantile hemangiomas

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

ED | Editorial

Author: de Lucas Laguna R1.
1Hospital Universitario La Paz. Madrid. Madrid. España.
Correspondence: Raul de Lucas Laguna. Email: rauldelucas@gmail.com
Publication date: 01/12/2011

How to cite this article

De Lucas Laguna R. Tratamiento de los hemangiomas infantiles con propranolol. Evid Pediatr. 2011;7:79.

ED | Editorial

Author: de Lucas Laguna R1.
1Hospital Universitario La Paz. Madrid. Madrid. España.
Correspondence: Raul de Lucas Laguna. Email: rauldelucas@gmail.com
Publication date: 01/12/2011

How to cite this article

De Lucas Laguna R. Tratamiento de los hemangiomas infantiles con propranolol. Evid Pediatr. 2011;7:79.

References

  1. Mulliken JB. Vascular malformations of the head and neck. Mulliken JB, Young AE (eds): Vascular birthmarks: Hemangiomas and vascular malformations. Philadelphia: WB Saunders; 1988.
  2. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138:1567-76.
  3. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006;118:882-7.
  4. Burgos L, López Gutiérrez JC, Andrés AM, Encinas JL, Luis AL, Suárez O et al. Early surgical treatment in nasal tip hemangiomas: 36 cases review. Cir Pediatr. 2007;20:83-6.
  5. Abdulkerim A, Boyd JA, Reeves RJ. Treatment of hemangioma of the skin in infancy and childhood by roentgen irradiation and radium: a report of 323 cases. Pediatrics. 1954;14:523-7.
  6. Greene AK, Couto RA. Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. Plast Reconstr Surg. 2011;128:743-52.
  7. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;28:326:1456-63.
  8. Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, Mac Donald D, Folkman J et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr.1998 Mar;132 (3 Pt 1):527-30.
  9. Glade RS, Vinson K, Becton D, Bhutta S, Buckmiller LM. Management of complicated hemangiomas with vincristine/vinblastine: Quantitative response to therapy using MRI. Int J Pediatr Otorhinolaryngol. 2010;74:1221-5.
  10. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649-51.
  11. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics. 2011;128: 259-66
  12. Rivas Fernández MA, Buñuel Álvarez JC. Propranolol: ¿futuro o presente en el tratamiento de los hemangiomas infantiles? Evid Pediatr. 2011;7:93.
  13. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol. 2010;163:269-74.
  14. Bagazgoitia L, Torrelo A, Gutiérrez JC, Hernández-Martín A, Luna P, Gutiérrez M et al. Propranolol for infantile hemangiomas. Pediatr Dermatol. 2011;28:108-14.
  15. Schupp CJ, Kleber JB, Günther P, Holland-Cunz S. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome. Pediatr Dermatol. 2011;28:640-4.
  16. Bagazgoitia L, Hernández-Martín A, Torrelo A. Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol. 2011;28:658-62.

Related Articles

AVC | Propranolol: future or present in the treatment of infantile hemangiomas?

Rivas Fernández MA, Buñuel Álvarez JC. Propranolol: ¿futuro o presente en el tratamiento de los hemangiomas infantiles? Evid Pediatr. 2011;7:93.
01/12/2011

Linked Comment